RINOGERMINA package nasal spray biological barrier 10 ml

Our nasal mucosa is inhabited by a large number of different bacteria. Good and bad. Their composition is essential for the health of our upper respiratory tract. If bad bacteria predominate - pathogenic, there is an infection of the sinuses or inflammation of the middle ear.

RINOGERMINA® is designed to strengthen and restore the natural protective bio-barrier of the nasal mucosa. It contains an effective combination of good, probiotic bacteria, which effectively limit the multiplication of bad - pathogenic bacteria on the mucous membranes of the upper respiratory tract.

In addition, RINOGERMINA® contains substances that

Contains 2 live bacteria

These two selected strains of probiotic bacteria have an exceptional ability to adhere strongly to the mucosa (adhesion) and multiply rapidly, thus effectively preventing pathogenic bacteria from active.

RINOGERMINA® is active on 3 levels

1. Barrier effect

Rinogermina® prevents any contact of pathogens with the host epithelium.
Rinogerminy® probiotic bacteria rapidly colonize the nasal mucosa. They create a barrier against pathogenic bacteria, which we inhale from the surrounding air.

Rinogermina® thus limits the ability of pathogens to settle, then multiply and cause an inflammatory infection.

2. Competitive "fight" for living space

Rinogerminy® probiotic bacteria compete with pathogens in the fight for living space. They are antagonists for pathogens that worsen their living conditions:

Rinogerminy® bacteria have better adhesion to the epithelium of the nasal mucosa. They attach quickly to it and are very viable.
They multiply and consume nutrients, thus worsening the living conditions for pathogens.
They occupy the space on the nasal mucosa, pathogens have no room to attach, they have a difficult supply of nutrients.
Pathogens thus have difficult conditions for their growth and reproduction. They lose the ability to cause infectious disease.

3. Restoration of normal saprophytic flora

Bacteria that are not pathogenic but necessary for us live on the surface of the nasal mucosa of healthy people. They ensure the resistance of the upper respiratory tract, which is the gateway to the inhaled air and the microorganisms contained in it. They are called saprophytic bacteria and are a natural part of the body. They live with us in symbiosis.

Upper respiratory tract infections (as well as antibiotic treatment itself) cause changes in the mucous membranes and the composition of saprophytic bacteria. Such mucosa is exposed to pathogens from the inhaled air, which can cause further infection under suitable conditions.

Dosage - adults and children:

Twice a day 2 injections (min. 5 x 109 CFU) into each nostril, for 7 consecutive days.
Repeat treatment once a month for 3 months